Adjunctive statistical standardization of quantitated adjuvant ER and PgR in CCTG MA. 27.
Judy-Anne Williams Chapman , Jane Bayani , Sandip SenGupta , John MS Battlett
Journal of Clinical Oncology 42 ( 16_suppl) 567 -567
2024
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17
Paul E Goss , James N Ingle , Silvana Martino , Nicholas J Robert
Yearbook of Oncology 2007 52 -53
1,405
2007
An international randomized phase III trial comparing radical hysterectomy and pelvic node dissection (RH) vs simple hysterectomy and pelvic node dissection (SH) in patients with low-risk early-stage cervical cancer (LRESCC): A Gynecologic Cancer Intergroup study led by the Canadian Cancer Trials Group (CCTG CX. 5-SHAPE).
Marie Plante , Janice S Kwon , Sarah Ferguson , Vanessa Samouëlian
Journal of Clinical Oncology 41 ( 17_suppl) LBA5511 -LBA5511
34
2023
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer
Marie Plante , Janice S Kwon , Sarah Ferguson , Vanessa Samouëlian
New England Journal of Medicine 390 ( 9) 819 -829
21
2024
Breast Cancer-Randomized Trial of Intensive Cyclophosphamide, Epirubicin, and Fluorouracil Chemotherapy Compared With Cyclophosphamide, Methotrexate, and Fluorouracil in Premenopausal Women With
Mark N Levine , Vivian H Bramwell , Kathleen I Pritchard , Brian D Norris
Journal of Clinical Oncology 16 ( 8) 2651 -2658
2
1998
# 142 An international randomized phase III trial comparing radical hysterectomy and pelvic node dissection (RH) vs simple hysterectomy and pelvic node dissection (SH) in patients with low-risk early-stage cervical cancer (LRESCC)
Marie Plante , Janice Kwon , Sarah Ferguson , Vanessa Samouëlian
International Journal of Gynecologic Cancer 33 ( Suppl 3)
1
2023
256 Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer from the CCTG CX. 5 ‘SHAPE’phase III clinical trial
Janice S Kwon , Marie Plante , Sarah Ferguson , Helen Mctaggart-Cowan
International Journal of Gynecologic Cancer 34 ( Suppl 1)
2024
Original Reports-BREAST CANCER-Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study
Edith A Perez , Robert G Josse , Kathleen I Pritchard , James N Ingle
Journal of Clinical Oncology 24 ( 22) 3629 -3635
2006
Original Reports-SUPPORTIVE CARE AND QUALITY OF LIFE-Assessment of Quality of Life in MA. 17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal Women
Timothy J Whelan , Paul E Goss , James N Ingle , Joseph L Pater
Journal of Clinical Oncology 23 ( 28) 6931 -6940
2005
Original Reports-BREAST CANCER-Randomized Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With Cyclophosphamide, Methotrexate, and Fluorouracil in Premenopausal Women With
Mark N Levine , Kathleen I Pritchard , Vivien HC Bramwell , Lois E Shepherd
Journal of Clinical Oncology 23 ( 22) 5166 -5170
2005
Pharmacokinetic analysis of tamoxifen metabolites in premenopausal women with early breast cancer: A substudy of NCIC CTG MA.12 randomized clinical trial.
Shahbal Bill Kangarloo , Ella SM Ng , Vivien HC Bramwell , Kathleen I Pritchard
Journal of Clinical Oncology 32 ( 15_suppl) 1524 -1524
2014
Effect of metformin versus placebo on metabolic factors in the MA. 32 randomized breast cancer trial
Pamela J Goodwin , Ryan JO Dowling , Marguerite Ennis , Bingshu E Chen
Npj breast cancer 7 ( 1) 74 -74
20
2021
Competing risks of death in younger and older postmenopausal breast cancer patients
Judy-Anne W Chapman , Kathleen I Pritchard , Paul E Goss , James N Ingle
World journal of clinical oncology 5 ( 5) 1088 -1096
9
2014
Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32
Ana Elisa Lohmann , Mira F Liebman , William Brien , Wendy R Parulekar
Breast Cancer Research and Treatment 164 ( 2) 371 -378
5
2017
Contact days associated with cancer treatments in the CCTG LY. 12 Trial
Arjun Gupta , Annette E Hay , Michael Crump , Marina S Djurfeldt
The Oncologist 28 ( 9) 799 -803
8
2023
Cancer antigen 15-3/mucin 1 levels in CCTG MA. 32: A breast cancer randomized trial of metformin vs placebo
Pamela J Goodwin , Ryan JO Dowling , Marguerite Ennis , Bingshu E Chen
JNCI cancer spectrum 5 ( 5) pkab066 -pkab066
8
2021
Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA. 32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer
Pamela J Goodwin , Bingshu E Chen , Karen A Gelmon , Timothy J Whelan
Journal of Clinical Oncology 41 ( 35) 5356 -5356
6
2023
A prospective economic analysis of early outcome data from the Alliance A041202/CCTG CLC. 2 randomized phase III trial of bendamustine-rituximab compared with ibrutinib-based regimens in untreated older patients with chronic lymphocytic leukemia
Matthew C Cheung , Nicole Mittmann , Carolyn Owen , Nizar Abdel-Samad
Clinical Lymphoma Myeloma and Leukemia 21 ( 11) 766 -774
6
2021
Abstract GS1-08: CCTGMA. 32, a phase III randomized double-blind placebo controlled adjuvant trial of metformin (MET) vs placebo (PLAC) in early breast cancer (BC): results of the primary efficacy analysis (clinical trials. gov NCT01101438)
Pamela J Goodwin , Bingshu E Chen , Karen A Gelmon , Timothy J Whelan
Cancer Research 82 ( 4_Supplement) GS1 -GS1
3
2022
Association between definitive surgery and times to administration of adjuvant chemotherapy and outcomes in early breast cancer: Analysis of adjuvant studies conducted by NCIC clinical trials group (NCIC CTG)
Ravi Ramjeesingh , Bingshu E Chen , Joseph L Pater , Liting Zhu
Cancer Research 75 ( 9)
3
2015